Cabaletta Bio, Inc.
CABA • NASDAQ
Cabaletta Bio, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Steven A. Nichtberger, with a market cap of $224.3M.
CEOSteven A. Nichtberger
Market Cap$224.3M
Biotechnology
Healthcare
Employees120.0
Websitecabalettabio.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Cabaletta Bio, Inc.
Date
Monday, March 30, 2026 (in 2 months)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.46
Revenue Estimate
$833.3K
Earnings History
Past 12 earnings reports for Cabaletta Bio, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 2025 | Q3 2025 | -$0.44Est: -$0.47 | +6.4% | -Est: $833.3K | -100.0% |  10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.73Est: -$0.65 | -12.3% | -Est: $4.2M | -100.0% | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.71Est: -$0.66 | -7.6% | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.65Est: -$0.64 | -1.6% | - | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.62Est: -$0.60 | -3.3% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.56Est: -$0.55 | -1.8% | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$0.51Est: -$0.44 | -15.9% | - | — | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$0.46Est: -$0.39 | -17.9% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.37Est: -$0.40 | +7.5% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.37Est: -$0.44 | +15.9% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.45Est: -$0.48 | +6.2% | - | — | 10-Q |
| Mar 16, 2023 | Q4 2022 | $0.52Est: -$0.45 | +215.6% | - | — | — |